SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
March 25, 2003
ENHANCE BIOTECH, INC.
(Exact name of issuer as specified in its charter)
(formerly called BECOR COMMUNICATIONS, INC.)
Delaware
(State or other jurisdiction of incorporation)
0-31653 95-4766094
(Commission File Number) (IRS Employer Identification No.)
17337 Ventura Boulevard, Suite 224, Encino, CA 91316
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (818) 784-0040
1
Item 1. Changes in Control of Registrant.
--------------------------------
NOT APPLICABLE
Item 2. Acquisition or Disposition of Assets.
------------------------------------
NOT APPLICABLE
Item 3. Bankruptcy or Receivership.
--------------------------
NOT APPLICABLE
Item 4. Change in Registrant's Certifying Accountants
---------------------------------------------
NOT APPLICABLE
Item 5. Other Events.
------------
On March 25, 2003, Registrant filed a "Certificate of Amendment To
Certificate of Incorporation of Becor Communications, Inc." with the Delaware
Secretary of State pursuant to which Registrant changed its name to ENHANCE
BIOTECH, INC. The name change was approved by the majority written consent of
the shareholders of Registrant.
Item 6. Resignations of Registrant's Directors.
--------------------------------------
NOT APPLICABLE
Item 7. Financial Statements and Exhibits.
---------------------------------
NOT APPLICABLE
Item 8. Change in Fiscal Year.
---------------------
NOT APPLICABLE
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
ENHANCE BIOTECH, INC.,
A California corporation (Registrant)
Date: March 26, 2003 By: /S/ BUDDY YOUNG
-------------------------------------
BUDDY YOUNG, Chief Executive
Officer
3